EN
抗体药类似物
Research Grade Nirsevimab
All
TD-VK421026_1.jpg
TD-VK421026_2.jpg
TD-VK421026_3.jpg
  • CatalogTD-VK421026
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsMEDI-8897,MEDI8897,CAS:1989556-22-0
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Nirsevimab


Catalog No. TD-VK421026
Species reactivity HRSV-A
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1, kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target F, Fusion glycoprotein F0, Fusion glycoprotein F2, p27, Intervening segment, Pep27, Peptide 27, Fusion glycoprotein F1
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P03420
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names MEDI-8897,MEDI8897,CAS:1989556-22-0
Background Nirsevimab (MEDI8897) is a recombinant monoclonal antibody against human respiratory syncytial virus (RSV). Nirsevimab has neutralizing activity against RSV A and RSV B viruses, with IC50 values of 5.42 ng/mL and 9.71 ng/mL, respectively. Nirsevimab can be used for research on respiratory infections.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-VK421026_1.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Nirsevimab.
TD-VK421026_2.jpg
SEC-HPLC
 
SEC-HPLC detection for Research Grade Nirsevimab.
TD-VK421026_3.jpg
Bioactivity
 
Detects Human F/Fusion glycoprotein F0 in indirect ELISAs.